Procurement Summary
Country : Brazil
Summary : Acquisition of Medicines (Antithymocyte Immunoglobulin 25 Mg F/A, Human Immunoglobulin 5.0 G F/A, Human Insulin Nph 100Ui/Ml Frs 10Ml)
Deadline : 05 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 95447292
Document Ref. No. : 77/2023
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of MEDICINES (ANTITHYMOCYTE IMMUNOGLOBULIN 25 MG F/A, HUMAN IMMUNOGLOBULIN 5.0 G F/A, HUMAN INSULIN NPH 100UI/ML FRS 10ML)
UASG Code: 250059
Notice from: 18/01 /2024 from 8:00 am to 12:00 pm and from 1:00 pm to 5:00 pm
Proposal Delivery: from19981d172c851bd4e8a1788d5726c2d3and 01/18/2024 at 08:00h
HUMAN ANTITHYMOCYTE IMMUNOGLOBULIN, RABBIT TYPE, CONCENTRATION 25 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION
Quantity: 200
HUMAN IMMUNOGLOBULIN, CONCENTRATION 5 G, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION INJECTABLE DILUENT
Quantity: 400
INSULIN, HUMAN ORIGIN, TYPE19981d172c851bd4e8a1788d5726c2d3NPH, DOSAGE 100U/ML, INJECTABLE APPLICATION
Quantity: 1824
INSULIN, HUMAN ORIGIN, REGULAR TYPE, DOSAGE 100U/ML, INJECTABLE APPLICATION
Quantity: 2500
PROTAMINE HYCLORHYDRATE, CONCENTRATION 1%, INJECTABLE SOLUTION PRESENTATION
Quantity: 109 44
RITUxIMAB, DOSAGE 10MG/ML, INJECTABLE SOLUTION INDICATION
19981d172c851bd4e8a1788d5726c2d3Quantity: 100
SURGICAL ADHESIVE, ACTIVE PRINCIPLE OF POLYETHYLENE GLYCOL (PEG), PHYSICAL APPEARANCE TOPICAL FREEZE DRIED POWDER DILUENT, ADDITIONAL WITH APPLICATOR, SINGLE USE TYPE, STERILITY* STERILE, SET PACKAGING
Quantity: 100
SURGICAL SEALANT, COMPOSITION 1 FIBRINOGEN, APROTININ, THROMBIN, 19981d172c851bd4e8a1788d5726c2d3COMPOSITION2 CALCIUM CHLORIDE, PHARMACEUTICAL FORM 1 LYOPHIL POWDER TOPIC DILUENT, ADDITIONAL CHARACTERISTICS WITH APPLICATION SET, TOTAL VOLUME 2 ML
Quantity: 315
SURGICAL SEALANT, COMPOSITION 1 FIBRINOGEN, APROTININ, THROMBIN, COMPOSITION2 CAPACITY CHLORIDE LCIO, PHARMACEUTICAL FORM 1 SOLUTION TO19981d172c851bd4e8a1788d5726c2d3PICA, ADDITIONAL CHARACTERISTICS WITH APPLICATION SET, TOTAL VOLUME 4 ML
Quantity: 239
TIROFIBAN HYCLORHYDRATE, DOSAGE 0.25 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 115
Documents
Tender Notice